Accueil > Actualité
Actualite financiere : Actualite bourse

Novartis: Stifel upgrades stock

( - Stifel has upgraded its rating on Novartis shares from Hold to Buy.

The analyst has also raised his target price for the shares from 89 Swiss francs to 97 Swiss francs, given the growing gap between consensus and its own assumptions for future sales and core EBIT, the analyst says.

We see a reversal in investor sentiment towards Novartis, Stifel said, noting that the company's recent positive announcements on Pluvicto (advanced prostate cancer) and Kisqali (breast cancer) more than offset the broker's conservative view on Leqvio (cholesterol).

Copyright (c) 2022 All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.